About
Science
Platform
Team
News
Lorem ipsum
Quisque
Integer
Contact
News & Events
News from Morphimmune
Targeted therapies developed to reduce lung fibrosis
•
June 1, 2021
Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs
•
June 1, 2021
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
•
June 1, 2021
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
•
June 1, 2021
Latest Press Realease
MorphImmune, Inc. Appoints Ronald Martell as President and CEO
•
June 2, 2021
Contact
Connect With Us
Do you have any questions or just want to connect? We would love to hear from you.
Name
Email
Message
Send Message